Year: 2020
Language: English
Author(s): World Federation of Hemophilia
In this session from the WFH 2020 Virtual Summit, Assad Haffar, Megan Adediran, Kibet Shikuku, Glenn Pierce, Alain Baumann, Bill Sibold, Guido Oelkers, Iqbal Mufti, Klaus Marten, Lauren Syring & Antti Kourula discuss the WFH Humanitarian Aid Program, which improves access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries.
This session will present its achievements of the past 5 years, while highlighting current donation commitments for future years, how the humanitarian aid program can help in implementing sustainable care to developing countries around the world and explore the possibility of gene therapy for a sustainable future.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.
The Report on Annual Global Survey (AGS) includes demographic and treatment data, providing a global snapshot of people with hemophilia,
The World Federation of Hemophilia invited representatives from its national member organizations, national governments, healthcare providers, industry partners, and other
A summary of discussions held at the Thirteenth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which
A summary of discussions held at the Twelfth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which
Welcome to this exciting webinar, a collaborative effort between the Nurses Committees of the European Association for Haemophilia and Allied
This video gives a quick introduction to ultra-long half-life (UHL) clotting factor replacement therapy. Learn more about different treatment options
